GSFK_PENAE
ID GSFK_PENAE Reviewed; 251 AA.
AC D7PI11;
DT 06-JUL-2016, integrated into UniProtKB/Swiss-Prot.
DT 10-AUG-2010, sequence version 1.
DT 03-AUG-2022, entry version 29.
DE RecName: Full=Short chain dehydrogenase gsfK {ECO:0000303|PubMed:20534346};
DE EC=1.-.-.- {ECO:0000305|PubMed:20534346};
DE AltName: Full=Griseofulvin synthesis protein K {ECO:0000303|PubMed:20534346};
GN Name=gsfK {ECO:0000303|PubMed:20534346};
OS Penicillium aethiopicum.
OC Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Eurotiomycetes;
OC Eurotiomycetidae; Eurotiales; Aspergillaceae; Penicillium.
OX NCBI_TaxID=36650;
RN [1]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND FUNCTION.
RC STRAIN=IBT 5753;
RX PubMed=20534346; DOI=10.1016/j.chembiol.2010.03.015;
RA Chooi Y.H., Cacho R., Tang Y.;
RT "Identification of the viridicatumtoxin and griseofulvin gene clusters from
RT Penicillium aethiopicum.";
RL Chem. Biol. 17:483-494(2010).
RN [2]
RP BIOTECHNOLOGY.
RX PubMed=13577889; DOI=10.1038/182476a0;
RA Gentles J.C.;
RT "Experimental ringworm in guinea pigs: oral treatment with griseofulvin.";
RL Nature 182:476-477(1958).
RN [3]
RP BIOTECHNOLOGY.
RX PubMed=4583105; DOI=10.1038/244292a0;
RA Gull K., Trinci A.P.;
RT "Griseofulvin inhibits fungal mitosis.";
RL Nature 244:292-294(1973).
RN [4]
RP FUNCTION.
RX PubMed=23978092; DOI=10.1021/cb400541z;
RA Cacho R.A., Chooi Y.H., Zhou H., Tang Y.;
RT "Complexity generation in fungal polyketide biosynthesis: a spirocycle-
RT forming P450 in the concise pathway to the antifungal drug griseofulvin.";
RL ACS Chem. Biol. 8:2322-2330(2013).
CC -!- FUNCTION: Short chain dehydrogenase; part of the gene cluster that
CC mediates the biosynthesis of griseofulvin, an important antifungal drug
CC that has been in use for a long time for treating dermatophyte
CC infections (PubMed:20534346, PubMed:23978092). The first step of the
CC pathway is the formation of the heptaketide backbone by gsfA which is
CC initiated by priming with acetyl-CoA, followed by sequential
CC condensations of 6 malonyl-CoA units (PubMed:20534346). O-methylation
CC at 3-OH by gsfB leads to griseophenone D which is further methylated at
CC 9-OH by gsfC to yield griseophenone C (PubMed:23978092). Griseophenone
CC C is then substrate of halogenase gsfI which is responsible for the
CC regio-specific chlorination at the C13 position to form griseophenone B
CC (PubMed:23978092). The cytochrome P450 gsfF catalyzes the coupling of
CC orcinol and phloroglucinol rings in griseophenone B to form desmethyl-
CC dehydrogriseofulvin A which is further methylated at 5-OH by gsfD to
CC yield dehydrogriseofulvin (PubMed:23978092). Finally, gsfE performs
CC stereospecific reduction of enone 18 of dehydrogriseofulvin to afford
CC the final product griseofulvin (PubMed:23978092). The exact role of
CC gsfK within the pathway has not been identified yet (PubMed:23978092).
CC {ECO:0000269|PubMed:20534346, ECO:0000269|PubMed:23978092}.
CC -!- PATHWAY: Secondary metabolite biosynthesis; terpenoid biosynthesis.
CC {ECO:0000269|PubMed:20534346, ECO:0000269|PubMed:23978092}.
CC -!- BIOTECHNOLOGY: Griseofulvin is a spirocyclic fungal natural product
CC used in treatment of fungal dermatophytes (PubMed:13577889,
CC PubMed:4583105). {ECO:0000269|PubMed:13577889,
CC ECO:0000269|PubMed:4583105}.
CC -!- SIMILARITY: Belongs to the short-chain dehydrogenases/reductases (SDR)
CC family. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; GU574478; ADI24951.1; -; Genomic_DNA.
DR AlphaFoldDB; D7PI11; -.
DR SMR; D7PI11; -.
DR UniPathway; UPA00213; -.
DR GO; GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW.
DR GO; GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW.
DR GO; GO:0016114; P:terpenoid biosynthetic process; IEA:UniProtKB-UniPathway.
DR InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR InterPro; IPR002347; SDR_fam.
DR Pfam; PF00106; adh_short; 1.
DR PRINTS; PR00081; GDHRDH.
DR SUPFAM; SSF51735; SSF51735; 1.
PE 1: Evidence at protein level;
KW NADP; Nucleotide-binding; Oxidoreductase.
FT CHAIN 1..251
FT /note="Short chain dehydrogenase gsfK"
FT /id="PRO_0000436725"
FT ACT_SITE 161
FT /evidence="ECO:0000250|UniProtKB:Q6PQJ9"
FT BINDING 11..13
FT /ligand="NADP(+)"
FT /ligand_id="ChEBI:CHEBI:58349"
FT /evidence="ECO:0000250|UniProtKB:Q6PQJ9"
FT BINDING 35..36
FT /ligand="NADP(+)"
FT /ligand_id="ChEBI:CHEBI:58349"
FT /evidence="ECO:0000250|UniProtKB:Q6PQJ9"
FT BINDING 142
FT /ligand="NADP(+)"
FT /ligand_id="ChEBI:CHEBI:58349"
FT /evidence="ECO:0000250|UniProtKB:Q6PQJ9"
SQ SEQUENCE 251 AA; 26235 MW; 25C1636B607A25F6 CRC64;
MPATVLITGG NRGLGKGLVA TYLSTPDTTV IATVRDPSKC ESLSALPKAL GSNLLLVKLE
VTSKDSITTA IGTLDTHNIG SIDVVIANAG ISGPTSSLAE APVSELQRYI DVNAYGPFEL
FKAVLPLLRS SNSGNKAKFV CISSAGGSLA AMYNFMPISA YGASKALANF LVKWLALDNK
DIIIWAQNPG SVDTDMARDG LDLAKSLGFD LSSLSFTSPE ESACAIKKLI DGATTEMSGK
FLDHDGSELA W